1. Home
  2. ARTL vs HIHO Comparison

ARTL vs HIHO Comparison

Compare ARTL & HIHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • HIHO
  • Stock Information
  • Founded
  • ARTL 2011
  • HIHO 1990
  • Country
  • ARTL United States
  • HIHO Hong Kong
  • Employees
  • ARTL N/A
  • HIHO N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • HIHO Industrial Machinery/Components
  • Sector
  • ARTL Health Care
  • HIHO Industrials
  • Exchange
  • ARTL Nasdaq
  • HIHO Nasdaq
  • Market Cap
  • ARTL 7.0M
  • HIHO 7.6M
  • IPO Year
  • ARTL N/A
  • HIHO 1996
  • Fundamental
  • Price
  • ARTL $5.47
  • HIHO $1.74
  • Analyst Decision
  • ARTL Buy
  • HIHO
  • Analyst Count
  • ARTL 2
  • HIHO 0
  • Target Price
  • ARTL $30.00
  • HIHO N/A
  • AVG Volume (30 Days)
  • ARTL 120.0K
  • HIHO 196.5K
  • Earning Date
  • ARTL 11-11-2025
  • HIHO 09-11-2025
  • Dividend Yield
  • ARTL N/A
  • HIHO 7.02%
  • EPS Growth
  • ARTL N/A
  • HIHO N/A
  • EPS
  • ARTL N/A
  • HIHO 0.01
  • Revenue
  • ARTL N/A
  • HIHO $7,080,000.00
  • Revenue This Year
  • ARTL N/A
  • HIHO N/A
  • Revenue Next Year
  • ARTL N/A
  • HIHO N/A
  • P/E Ratio
  • ARTL N/A
  • HIHO $182.23
  • Revenue Growth
  • ARTL N/A
  • HIHO 3.31
  • 52 Week Low
  • ARTL $4.20
  • HIHO $1.40
  • 52 Week High
  • ARTL $28.60
  • HIHO $2.88
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 33.32
  • HIHO 55.44
  • Support Level
  • ARTL $4.60
  • HIHO $1.59
  • Resistance Level
  • ARTL $5.75
  • HIHO $1.83
  • Average True Range (ATR)
  • ARTL 0.52
  • HIHO 0.11
  • MACD
  • ARTL -0.07
  • HIHO 0.00
  • Stochastic Oscillator
  • ARTL 24.52
  • HIHO 41.67

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

Share on Social Networks: